Although LW6 is synthesized as an (aryloxyacetylamino)benzoic acid derivative (Fig. 1A) and has the potential to inhibit the expression of HIF-1α in the HCT116 human colon cancer cell line (17), its mechanism of action has remained to be fully elucidated. This evidence concerns the gene HIF1A and colonic neoplasm.